통합검색
내가 찾은 검색어
'Immune checkpoint inhibitor' 에 대한 통합검색결과 105건입니다.
한빛사105건
-
Tumor cell-derived lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
- Mol. Ther. December 31, 2024 | https://doi.org/10.1016/j.ymthe.2024.12.044
- 2025.12
- 생명과학
-
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
- Nat. Med. Jan 06 2025, | https://doi.org/10.1038/s41591-024-03398-5
- 2025.01
- 의약학
-
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
- Clin. Mol. Hepatol. Dec 26 2024, | https://doi.org/10.3350/cmh.2024.0824
- 2024.12
-
Self-assembled Peptide-derived Proteolysis-targeting Chimera (PROTAC) Nanoparticles for Tumor-targeted and Durable PD-L1 Degradation in Cancer Immunot
- Angew. Chem.-Int. Edit. Nov 21 2024, | https://doi.org/10.1002/anie.202414146
- 2024.11
- 바이오·의료융합
-
RNA N6-Methyladenosine-Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN-γ Signaling in Gastric Cancer
- Adv. Sci. Nov 25 2024, | https://doi.org/10.1002/advs.202410806
- 2024.11
- 의약학
-
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
- Hepatology November 21, 2024. | DOI: 10.1097/HEP.0000000000001163
- 2024.11
- 의약학
-
Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis
- Proc. Natl. Acad. Sci. USA 024 Oct 15;121(42):e2323052121 | https://doi.org/10.1073/pnas.2323052121
- 2024.10
-
Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma
- J. Immunother. Cancer Oct 26 2024, 12 (10) e009449 | https://doi.org/10.1136/jitc-2024-009449
- 2024.10
- 생명과학
-
Spatially resolved whole-transcriptomic and proteomic profiling of lung cancer and its immune-microenvironment according to PD-L1 expression
- Cancer Immunol. Res. Sep 05 2024, | https://doi.org/10.1158/2326-6066.CIR-24-0071
- 2024.09
- 의약학
-
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors
- J. Immunother. Cancer Sep 28 2024, 12 (9) e009128 | https://doi.org/10.1136/jitc-2024-009128
- 2024.09
- 의약학
-
Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment
- Adv. Mater. Sep 10 2024, | https://doi.org/10.1002/adma.202410340
- 2024.09
- 바이오·의료융합
-
Nanobubble-Based Acoustical Bursting of Nuclear Membrane for Interleukin-33 Release Induces Eosinophil-Mediated Cancer Immunotherapy
- Adv. Funct. Mater. 20 September 2024 | https://doi.org/10.1002/adfm.202407577
- 2024.09
- 바이오·의료융합
-
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
- Liver Cancer August 20 2024 | https://doi.org/10.1159/000540969
- 2024.08
- 의약학
-
Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
- Cell Host Microbe July 25, 2024 | https://doi.org/10.1016/j.chom.2024.06.010
- 2024.07
- 의약학
-
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial
- J. Immunother. Cancer Jul 04 2024, 12 (7) e009058 | https://doi.org/10.1136/jitc-2024-009058
- 2024.07
- 의약학
-
Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers
- Acta Pharm. Sin. B Available online 10 July 2024 | https://doi.org/10.1016/j.apsb.2024.07.011
- 2024.07
- 의약학
-
Dual Adjuvant-Loaded Peptide Antigen Self-Assembly Potentiates Dendritic Cell-Mediated Tumor Immunotherapy
- Adv. Sci. Jul 29 2024, | https://doi.org/10.1002/advs.202403663
- 2024.07
- 생명과학
-
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort
- J. Immunother. Cancer Jul 27 2024, 12 (7) e009074 | https://doi.org/10.1136/jitc-2024-009074
- 2024.07
- 의약학
-
Novel insights into paclitaxel‘s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
- J. Immunother. Cancer Jul 15 2024, 12 (7) e008864 | https://jitc.bmj.com/content/12/7/e008864
- 2024.07
- 의약학
-
Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy,
- Liver Cancer Jun 2024, 13 (3) | https://doi.org/10.1159/000534303
- 2024.06
